Italian Journal of Medicine <p>The <strong>Italian Journal of Medicine (ITJM)</strong> is the official journal of FADOI, the Federation of Associations of Hospital Doctors on Internal Medicine and focus to describe the complex and variable situations confronted by Internists in daily practice. ITJM aims to promote excellence in the practice of internal medicine in hospitals and to disseminate the results of clinical research in internal medicine departments. The journal also contributes to the updating of hospital internists on general topics concerning public health, including ethical, legal, economical and health policy issues. The <strong>Italian Journal of Medicine (ITJM)</strong> is a quarterly peer-reviewed journal aiming to publish highest-quality material covering original basic and clinical research on all aspects of internal medicine. The Journal includes original clinical research papers, reviews, case reports and specific sections dedicated to clinical pharmacology, chronic diseases, health management. The Italian Journal of Medicine is currently indexed in <a title="Scopus" href="" target="_blank" rel="noopener">Scopus</a> and <a title="DOAJ" href="" target="_blank" rel="noopener">DOAJ</a> since September 2009.</p> en-US <p><strong>PAGEPress</strong> has chosen to apply the&nbsp;<a href="" target="_blank" rel="noopener"><strong>Creative Commons Attribution NonCommercial 4.0 International License</strong></a>&nbsp;(CC BY-NC 4.0) to all manuscripts to be published.<br><br> An Open Access Publication is one that meets the following two conditions:</p> <ol> <li>the author(s) and copyright holder(s) grant(s) to all users a free, irrevocable, worldwide, perpetual right of access to, and a license to copy, use, distribute, transmit and display the work publicly and to make and distribute derivative works, in any digital medium for any responsible purpose, subject to proper attribution of authorship, as well as the right to make small numbers of printed copies for their personal use.</li> <li>a complete version of the work and all supplemental materials, including a copy of the permission as stated above, in a suitable standard electronic format is deposited immediately upon initial publication in at least one online repository that is supported by an academic institution, scholarly society, government agency, or other well-established organization that seeks to enable open access, unrestricted distribution, interoperability, and long-term archiving.</li> </ol> <p>Authors who publish with this journal agree to the following terms:</p> <ol> <li>Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.</li> <li>Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.</li> <li>Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.</li> </ol> (Paola Granata) (Tiziano Taccini) Mon, 10 Sep 2018 00:00:00 +0200 OJS 60 L'internista naviga nel mare salato che è in noi <p><img src="/public/site/images/pgranata/rass.jpg" alt=""><br><strong>Il mare vivo che è in noi</strong><br><em>F. Sgambato, S. Prozzo, E. Sgambato<br><br></em><strong>Meccanismi fisiologici del ricambio di sodio ed acqua</strong><br><em>M. Renis<br><br></em><strong>Le alterazioni del bilancio del sodio e dell’acqua</strong><br><em>M. Renis<br><br></em><strong>Approccio clinico-pratico ai disturbi dell’equilibrio acido-base</strong><br><em>A. Casola, L. Bianchi, S. Detrenis, S. Pioli, M. del Mar Jordana-Sanchez, T. Pasquariello, D. Fasano, M. Saccò, A. Magnano, F. Spagnoli, M. Meschi<br></em><em><img src="/public/site/images/pgranata/Sezioni5.jpg"><br></em><strong>Approccio clinico-diagnostico e strumentale alle iposodiemie ipotoniche e non ipotoniche</strong><br><em>I. Ambrosino<br><br></em><strong>Approccio clinico-diagnostico e strumentale alle ipersodiemie</strong><br><em>A. Ilardi<br><br></em><strong>La sindrome da inappropriata antidiuresi</strong><br><em>G. Tenconi, G. Secondo, L. Mortara<br></em><em><img src="/public/site/images/pgranata/Sezioni6.jpg"><br></em><strong>Approccio clinico-diagnostico e strumentale alle ipopotassiemie</strong><br><em>T.M. Attardo<br><br></em><strong>Approccio diagnostico e strumentale alle iperpotassiemie</strong><br><em>M. Gambacorta<br></em><em><img src="/public/site/images/pgranata/Sezioni7.jpg"><br></em><strong>Ipocalcemia: condizione comune a diverse patologie</strong><br><em>A. Montagnani, M. Alessandri, M. Migliorini<br><br></em><strong>Approccio clinico-diagnostico e strumentale alle ipercalcemie</strong><br><em>P. Gnerre, M. Grandi, A. Percivale<br><br></em><em><img src="/public/site/images/pgranata/Sezioni8.jpg"><br></em><strong>Approccio clinico-diagnostico e strumentale alle ipomagnesiemie e alle ipermagnesiemie</strong><br><em>L. Lenzi<br><br></em><em><img src="/public/site/images/pgranata/Sezioni9.jpg"><br></em><strong>Approccio al paziente con ipofosfatemia e iperfosfatemia</strong><br><em>M.T. De Donato<br><br></em><img src="/public/site/images/pgranata/concl.jpg" alt=""><br><strong>Conclusioni <br><em> hai sale in zucca?</em></strong><br><em>A. Fontanella</em></p> Guest Editors: M. Grandi, R. Frediani, A. Fontanella, P. Gnerre ##submission.copyrightStatement## Mon, 12 Nov 2018 12:33:08 +0100 Nursing clinical competence in area medica <p><strong>Introduzione</strong><br> <strong>Background</strong></p> <ul> <li><em>La nursing clinical competence</em></li> <li><em>Il concetto di clinical competence in medicina interna</em></li> <li><em>Declinare e classificare i livelli di competenza</em></li> <li><em>Aree di assistenza nei contesti di area medica</em><br>&nbsp; <ul> <li>Il paziente cronico</li> <li>Scompenso cardiaco</li> <li>La broncopneumopatia cronica e ostruttiva</li> <li>La cirrosi epatica</li> <li>La pancreatite</li> <li>Il diabete mellito</li> <li>Il delirium</li> <li>La depressione</li> <li>Il paziente critico</li> <li>L’ipertensione</li> <li>La trombosi venosa profonda</li> <li>L’ischemia cerebrale</li> <li>La disfagia</li> <li>Gli squilibri idroelettrolitici</li> <li>Le polmoniti</li> <li>I sanguinamenti gastro-intestinali</li> <li>La sepsi</li> <li>Il monitoraggio cardiaco</li> <li>La ventilazione non-invasiva</li> <li>L’ecografia operativa bedside</li> <li>Somministrazione di terapia e chemioterapia</li> <li>Le lesioni da pressione</li> <li>Il dolore</li> <li>Gli accessi vascolari</li> <li>Il paziente fragile</li> <li>La dimissione difficile</li> <li>Il fine vita</li> </ul> </li> </ul> <p><strong>Obiettivo</strong><br> <strong>Metodi</strong><br> <strong>Risultati</strong><br> <strong>Conclusioni</strong><br> <strong>Bibliografia</strong></p> Guest Editors: F. Bertoncini, C. Gatta, G. Pentella ##submission.copyrightStatement## Wed, 24 Oct 2018 09:35:54 +0200 Optimal duration of anticoagulant therapy in patients with venous thromboembolism <p>Venous thromboembolism (VTE), a frequent and severe disease, has clinically important early and late complications and a strong tendency to recur. Anticoagulant therapy is the mainstay of treatment, performed by immediate administration of: a) parenteral anticoagulants followed by vitamin K antagonists (VKAs), either dabigatran or edoxaban, two direct oral anticoagulants (DOACs); or b) direct rivaroxaban or apixaban, two DOACs that can be used as single-drug approach. Treatment should last no less than 3 months in all patients though how long it should last thereafter is a more complex issue. The risk of recurrence results from several event- or patient-associated factors. Some patients have low risk and may be treated for 3 to 6 months only. Others (the majority), have a high risk of recurrence (approximately 50% in 10 years). Unfortunately, the protective effect of anticoagulation against recurrence is present only during treatment and is lost when therapy is stopped. For this reason, international guidelines recommend there be no pre-definite period of anticoagulation (e.g. 1 or 2 years, and so on) in patients at high risk and suggest instead indefinite (extended) anticoagulation, provided there is no high risk of bleeding. When the decision is difficult, adjunctive criteria may be adopted, such as male sex and abnormal Ddimer assessed after anticoagulation is stopped, to identify patients at high risk who need indefinite therapy. The use of DOACs, especially at lower doses with a lower risk of bleeding, may make indefinite anticoagulation for patients easier.</p> Gualtiero Palareti ##submission.copyrightStatement## Fri, 14 Sep 2018 17:43:39 +0200